NeelamVijayDesaiMD

PubMed

• Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer.
  Neelam V Desai, Elizabeth D Barrows, Sarah M Nielsen, Kathryn E Hatchell, Michael J Anderson, Eden V Haverfield, Blanca Herrera, Anneke Lucassen, Nadine M Tung, Claudi...> ;JCO Precision Oncology. 2023 Aug 1
• 2 citations
  Targeted Therapies and the Evolving Standard of Care for Triple-Negative and Germline/-Mutated Breast Cancers in the High-Risk, Early-Stage Setting.
  Neelam V Desai, Antoinette R Tan> ;JCO Precision Oncology. 2023 May 1
• 1 citations
  Q and A: A New Standard of Care for Germlineand/orMutation Carriers With Early-Stage Breast Cancer.
  Neelam V Desai, Dana Zakalik, Mark R Somerfield, Nadine M Tung> ;JCO Oncology Practice. 2022 Jun 1
• 15 citations
  A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer.
  Adrienne G Waks, Neelam V Desai, Tianyu Li, Philip D Poorvu, Ann H Partridge, Natalie Sinclair, Laura M Spring, Meredith Faggen, Michael Constantine, Otto Metzger, Jil...> ;NPJ Breast Cancer. 2022 May 10
• 4 citations
  Germline Genetic Testing for Women With Breast Cancer: Shifting the Paradigm From Whom to Test to Whom NOT to Test.
  Nadine Tung, Neelam V. Desai> ;Journal of Clinical Oncology. 2021 Sep 7
• 18 citations
  Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk-based testing of those older than 60 years
  Neelam V. Desai, Siddhartha Yadav, Felipe Batalini, Fergus J. Couch, Nadine Tung> ;Cancer. 2021 Mar 15
• Medical Management of newly diagnosed breast cancer in a BRCA1/2 mutation carrier.
  Neelam V. Desai, Nadine Tung> ;The Breast Journal. 2020 Jul 6
• It is time to conduct phase 3 clinical trials of sex hormones in MS - No.
  Maria K. Houtchens, Neelam V. Desai> ;Multiple Sclerosis. 2018 Jul 30
• 5 citations
  Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay
  Neelam V. Desai, Vanda F. Torous, Joel S. Parker, James Todd Auman, Gary B. Rosson, Cassandra Cruz, Charles M. Perou, Stuart J. Schnitt, Nadine Tung> ;Breast Cancer Research. 2018 Jul 11
• 5 citations
  Clinical, morphologic, and immunophenotypic characteristics of ampullary carcinomas with an emphasis on SMAD4 expression.
  Ahmad Alkhasawneh, Lizette Vila Duckworth, Thomas J. George, Neelam Vijay Desai, Alex J Sommerfeld, Xiaomin Lu, Tania Zuluaga Toro> ;Journal of Gastrointestinal Oncology. 2016 Dec 1
• 16 citations
  Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer.
  Neelam Vijay Desai, Sarunas Sliesoraitis, Steven J. Hughes, Jose G. Trevino, Robert A. Zlotecki, Alison Marguerite Ivey, Thomas J. George> ;Cancer Medicine. 2015 Mar 13
• 21 citations
  De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors
  Xiuning Le, Neelam V. DeSai, Adnan Majid, Rebecca Karp, Mark S. Huberman, Deepa Rangachari, Michael S. Kent, Sidhu P. Gangadharan, Erik Folch, Paul A. VanderLaan, Dani...> ;Lung Cancer. 2015 Apr 1
• Join now to see all